Document is current
Any future updates will be listed below
-
Authors
Asiabi, P. https://orcid.org/0000-0002-5946-5158
Ambroise, J. https://orcid.org/0000-0002-1218-6143
Giachini, C. https://orcid.org/0000-0002-2155-7436
Coccia, M. E. https://orcid.org/0000-0001-5294-129X
Bearzatto, B. https://orcid.org/0000-0001-5193-6819
Chiti, M. C. https://orcid.org/0000-0002-0445-8946
Dolmans, M. M. https://orcid.org/0000-0002-6331-3026
Amorim, C. A. https://orcid.org/0000-0003-1794-0368
-
Funding
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS (MIS #F4535 16, 5/4/150/5, ASP-RE314, T.0077.14, 30443682)
- License Information
-
More Information
Article History
Received: 31 March 2020
Accepted: 23 July 2020
First Online: 30 July 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: Use of human ovarian tissue was approved by the Institutional Review Board of the Université Catholique de Louvain on November 28, 2016 (IRB reference 2012/23MAR/125, registration number B403201213872).Four PCOS samples came from the assisted reproduction technology center of the Careggi University Hospital in Florence, Italy (Ethical approval n. 11314_bio).
